Adient (NYSE:ADNT)‘s stock had its “hold” rating reiterated by equities research analysts at Barclays in a research report issued on Sunday. They currently have a $71.00 price target on the stock. Barclays’ target price would suggest a potential downside of 1.31% from the stock’s current price.
Other research analysts also recently issued reports about the company. Guggenheim reaffirmed a “hold” rating and set a $90.00 price target on shares of Adient in a report on Wednesday, January 10th. Longbow Research started coverage on Adient in a report on Friday, January 5th. They issued a “neutral” rating on the stock. Robert W. Baird lowered their target price on Adient from $90.00 to $89.00 and set an “outperform” rating on the stock in a report on Friday, November 3rd. Zacks Investment Research downgraded Adient from a “buy” rating to a “hold” rating in a report on Monday, November 6th. Finally, UBS Group lowered their target price on Adient from $98.00 to $95.00 and set a “buy” rating on the stock in a report on Friday, November 3rd. Two research analysts have rated the stock with a sell rating, five have assigned a hold rating, three have given a buy rating and one has assigned a strong buy rating to the company. Adient presently has a consensus rating of “Hold” and an average target price of $82.11.
Shares of Adient (ADNT) traded down $2.21 during trading hours on Friday, hitting $71.94. The stock had a trading volume of 2,136,887 shares, compared to its average volume of 1,099,996. The company has a market capitalization of $6,697.61, a P/E ratio of 7.60, a P/E/G ratio of 0.67 and a beta of -0.25. The company has a debt-to-equity ratio of 0.75, a quick ratio of 0.87 and a current ratio of 1.04. Adient has a 1 year low of $59.10 and a 1 year high of $86.42.
In other news, VP Cathleen A. Ebacher sold 9,184 shares of the firm’s stock in a transaction dated Tuesday, November 28th. The stock was sold at an average price of $78.40, for a total value of $720,025.60. Following the transaction, the vice president now owns 38,187 shares of the company’s stock, valued at $2,993,860.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link. Also, VP Cathleen A. Ebacher sold 2,584 shares of the firm’s stock in a transaction dated Monday, December 4th. The stock was sold at an average price of $79.13, for a total value of $204,471.92. Following the completion of the transaction, the vice president now directly owns 36,454 shares in the company, valued at approximately $2,884,605.02. The disclosure for this sale can be found here. In the last three months, insiders sold 79,525 shares of company stock worth $6,242,744. 0.14% of the stock is owned by corporate insiders.
COPYRIGHT VIOLATION WARNING: This report was originally published by American Banking News and is the property of of American Banking News. If you are reading this report on another site, it was illegally copied and republished in violation of international copyright and trademark legislation. The correct version of this report can be read at https://www.americanbankingnews.com/2018/01/21/adient-adnt-rating-reiterated-by-barclays.html.
Adient Company Profile
Adient plc, formerly Adient Limited, is an automotive seating supplier. The Company designs, manufactures and markets a range of seating systems and components for passenger cars, commercial vehicles, and light trucks, including vans, pick-up trucks, and sport/crossover utility vehicles. The Company operates through two segments: Seating and Interiors.
Receive News & Ratings for Adient Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Adient and related companies with MarketBeat.com's FREE daily email newsletter.